J7513 HCPCS Level II code: Daclizumab, parenteral, 25 mg
CMS terminated J7513: its last date of service was Dec 31, 2025. It stays here for looking up older claims; newer services need a current code.
Official description
J7513Daclizumab, parenteral, 25 mg
Short description: Daclizumab, parenteral
HCPCS · United States
Medicare details
The indicators CMS publishes with J7513 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Immunosuppressive drugs
- BETOS category
- Other drugs
- Added
- Jan 1, 1999
- Terminated after
- Dec 31, 2025
Where J7513 sits
- 1J codesDrugs administered other than orally
- 2Terminated J7513Daclizumab, parenteral, 25 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J7513 still valid?
No. CMS terminated J7513; its last date of service was Dec 31, 2025. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J7513?
CMS lists J7513’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7513
All J codesJ7507Tacrolimus, immediate release, oral, 1 mgJ7508Tacrolimus, extended release, (astagraf xl), oral, 0.1 mgJ7509Methylprednisolone oral, per 4 mgJ7510Prednisolone oral, per 5 mgJ7511Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mgJ7512Prednisone, immediate release or delayed release, oral, 1 mgJ7514Mycophenolate mofetil (myhibbin), oral suspension, 100 mgJ7515Cyclosporine, oral, 25 mgJ7516Injection, cyclosporine, 250 mgJ7517Mycophenolate mofetil, oral, 250 mgJ7518Mycophenolic acid, oral, 180 mgJ7519Injection, mycophenolate mofetil, 10 mg